Showing results (251-260 of 275) with videos related to

Sort By:
Pageof 28
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2012
Predominance of heavily calcified coccolithophores at low CaCO3 saturation during winter in the Bay of BiscayHelen E K Smith, Toby Tyrrell, Anastasia Charalampopoulou, et al.
Molecular Cancer Therapeutics|April 17, 2014
A small molecule that binds and inhibits the ETV1 transcription factor oncoproteinMarius S Pop, Nicolas Stransky, Colin W Garvie, et al.
Research Square|May 4, 2026
Development of a STEAP1-Targeted Prostate Cancer Specific Antibody Drug Conjugate Platform with Immunostimulatory PropertiesJohn Shuhan Wang, Sirajbir S Sodhi, Li-Chung Tsao, et al.
Chemistry & Biology|September 17, 2013
Optical and radioiodinated tethered Hsp90 inhibitors reveal selective internalization of ectopic Hsp90 in malignant breast tumor cellsJared J Barrott, Philip F Hughes, Takuya Osada, et al.
Oncogene|May 10, 2016
The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironmentJ Turpin, C Ling, E J Crosby, et al.
Human Vaccines & Immunotherapeutics|February 8, 2024
Vaccines targeting ESR1 activating mutations elicit anti-tumor immune responses and suppress estrogen signaling in therapy resistant ER+ breast cancerGabrielle P Dailey, Christopher A Rabiola, Gangjun Lei, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 27, 2026
Enhanced Efficacy of a Next-Generation EEEV Self-Replicating RNA Platform for Combination Cancer ImmunotherapiesShigeki J Miyake-Stoner, Christian J Maine, Annie C Chou, et al.
Molecular Cancer Therapeutics|June 16, 2011
Truncated ErbB2 expressed in tumor cell nuclei contributes to acquired therapeutic resistance to ErbB2 kinase inhibitorsWenle Xia, Zuguo Liu, Rongrong Zong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and enhanced therapeutic efficacy without oncogenicityZachary C Hartman, Junping Wei, Takuya Osada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2019
Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational StudyErika J Crosby, William Gwin, Kimberly Blackwell, et al.
Pageof 28